Table 1.
Gene | Model | Phenotype | Mitochondrial Morphology |
Reference |
---|---|---|---|---|
Drp1 | Drp1 deletion homo | Embryonically lethal | Reduced mitochondrial fission | [107] |
Drp1 deletion hetero | Similar to WT | |||
Cardiac Drp1 deletion (early postnatal) | Lethal | Enlarged, heterogeneity | [109] | |
Drp1 deletion (muscle-specific) | Lethal, Dilated heart | [110] | ||
Cardiac Drp1 KO (postnatal) | Lethal, Dilated heart | - | [111] | |
Cardiac Drp1 KO using tamoxifen (ad 8 weeks) | DCM, Fibrosis | Enlarged | ||
Cardiac Drp1 KO using tamoxifen (ad 15 weeks) | Hypertrophy, Fibrosis | Elongated | [108] | |
Cardiac Drp1 KO using tamoxifen (ad 8 weeks) | DCM | Enlarged | [112] | |
Overexpression of Drp1 (Transgenic mice) | Not deleterious | Fragmented | [113] | |
Mfn1/2 | Mfn1/2 KO | Embryonically lethal | - | [124] |
Cardiac Mfn1/2 KO (mid-gestational and postnatal) | Normal at birth Lethal DCM |
Spherical, heterogeneity | [114] | |
Cardiac Mfn1/2 KO (embryonic) | Cardiac development failure | Fragmented | [125] | |
Cardiac Mfn1/2 KO using tamoxifen (early embryonic) | Lethal | Fragmented | [115] | |
Cardiac Mfn1/2 KO using tamoxifen (within 8 weeks) | Lethal, DCM | |||
Cardiac Mfn1/2 KO (8 weeks–10 weeks) | Impaired myocardial function | Fragmented | [116] | |
Marf (Drosophila) | DCM | Spherical, Fragmented, heterogeneity | [121] | |
Mfn1 | Cardiac Mfn1 deletion | Normal | Spherical, small | [117,118] |
Cardiac Mfn1 deletion | Normal | Large | [126] | |
Mfn2 | Cardiac Mfn2 deletion | DCM | Enlarged | [118,119] |
Cardiac Mfn2 deletion | Normal | Heterogeneity | [126] | |
Drp1/Mfn1/Mfn2 | Cardiac triple knockout Mfn1/Mfn2/Drp1 | HCM | Fragmented | [113] |
Mff | Mff deletion | DCM | No changes, heterogeneity | [122] |
Opa1 | Opa1 KO | Embryonically lethal | - | [127] |
Heterozygous Opa1 KO | Normal | Enlarged | [123] |
Abbreviations: DCM—Dilated cardiomyopathy; HCM—Hypertrophic cardiomyopathy.